Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2023,Subtelomeric Heterochromatin Formation (GO:0031509),1/5,0.000999677239285086,0.0149896003256745,0,0,1666.0,11508.858100931304,EZH2
GO_Biological_Process_2023,Negative Regulation Of Retinoic Acid Receptor Signaling Pathway (GO:0048387),1/6,0.0011995241237685,0.0149896003256745,0,0,1332.7333333333331,8963.738320936684,EZH2
GO_Biological_Process_2023,UDP-N-acetylglucosamine Biosynthetic Process (GO:0006048),1/8,0.0015991284507528,0.0149896003256745,0,0,951.8571428571428,6128.338526995007,GNPNAT1
GO_Biological_Process_2023,Constitutive Heterochromatin Formation (GO:0140719),1/8,0.0015991284507528,0.0149896003256745,0,0,951.8571428571428,6128.338526995007,EZH2
GO_Biological_Process_2023,Amino Sugar Biosynthetic Process (GO:0046349),1/9,0.0017988858466888,0.0149896003256745,0,0,832.8333333333334,5263.9961892645415,GNPNAT1
GO_Biological_Process_2023,UDP-N-acetylglucosamine Metabolic Process (GO:0006047),1/10,0.0019986133767566,0.0149896003256745,0,0,740.2592592592592,4600.934595868677,GNPNAT1
GO_Biological_Process_2023,Regulation Of Retinoic Acid Receptor Signaling Pathway (GO:0048385),1/12,0.0023979788011638,0.0154155780074817,0,0,605.6060606060606,3653.699524747979,EZH2
GO_Biological_Process_2023,Nucleotide-Sugar Biosynthetic Process (GO:0009226),1/15,0.0029968027587318,0.0168570155178666,0,0,475.7619047619048,2764.2762463526265,GNPNAT1
GO_Biological_Process_2023,Positive Regulation Of Cell Cycle Phase Transition (GO:1901989),1/17,0.0033958692395375,0.0169793461976877,0,0,416.25,2366.4626333406177,EZH2
GO_Biological_Process_2023,Regulation Of Extracellular Matrix Organization (GO:1903053),1/23,0.0045923510335213,0.0206655796508459,0,0,302.6363636363636,1629.2014564159526,ZNF469
GO_Biological_Process_2023,Heterochromatin Formation (GO:0031507),1/32,0.006385055602597,0.0261206820106244,0,0,214.67741935483872,1084.93568598441,EZH2
GO_Biological_Process_2023,Heterochromatin Organization (GO:0070828),1/39,0.0077777077543161,0.0266310634002641,0,0,175.0701754385965,850.2271896016904,EZH2
GO_Biological_Process_2023,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),1/40,0.0079765385653122,0.0266310634002641,0,0,170.57264957264957,824.0792369758823,EZH2
GO_Biological_Process_2023,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),2/763,0.0082852197245266,0.0266310634002641,0,0,25.27595269382392,121.1547718021669,ZNF469;EZH2
GO_Biological_Process_2023,Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),1/47,0.009367518105959,0.028102554317877,0,0,144.56521739130434,675.1928734367539,EZH2
GO_Biological_Process_2023,"Negative Regulation Of Gene Expression, Epigenetic (GO:0045814)",1/51,0.010161706815005,0.0285798004172016,0,0,132.97333333333333,610.2317612564632,EZH2
GO_Biological_Process_2023,protein-DNA Complex Organization (GO:0071824),1/60,0.0119468861025562,0.0313535227676196,0,0,112.63841807909604,498.6823350537484,EZH2
GO_Biological_Process_2023,Telomere Organization (GO:0032200),1/63,0.0125414091070478,0.0313535227676196,0,0,107.17204301075267,469.2763018440373,EZH2
GO_Biological_Process_2023,Negative Regulation Of DNA-templated Transcription (GO:0045892),2/1025,0.0146913302130034,0.0331178226721558,0,0,18.54643206256109,78.2751746165136,ZNF469;EZH2
GO_Biological_Process_2023,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),1/74,0.0147190322987359,0.0331178226721558,0,0,90.97260273972604,383.7782872027407,EZH2
GO_Biological_Process_2023,Epigenetic Regulation Of Gene Expression (GO:0040029),1/83,0.0164980440743972,0.0337459992430853,0,0,80.95121951219512,332.2653689617683,EZH2
GO_Biological_Process_2023,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),1/83,0.0164980440743972,0.0337459992430853,0,0,80.95121951219512,332.2653689617683,EZH2
GO_Biological_Process_2023,Positive Regulation Of MAP Kinase Activity (GO:0043406),1/91,0.0180773648602116,0.0353687573351967,0,0,73.72592592592592,295.8691213711147,EZH2
GO_Biological_Process_2023,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.022214034124409,0.0401486990931107,0,0,59.71471471471472,227.33577139307437,EZH2
GO_Biological_Process_2023,Regulation Of MAP Kinase Activity (GO:0043405),1/114,0.0226073199078965,0.0401486990931107,0,0,58.65191740412979,222.26035801963076,EZH2
GO_Biological_Process_2023,Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),1/117,0.0231970261426861,0.0401486990931107,0,0,57.12643678160919,215.00855200452875,EZH2
GO_Biological_Process_2023,Positive Regulation Of Protein Kinase Activity (GO:0045860),1/145,0.0286880933828552,0.0478134889714253,0,0,45.9537037037037,163.1941521302671,EZH2
GO_Biological_Process_2023,Regulation Of Cellular Component Organization (GO:0051128),1/153,0.0302527091247538,0.0486204253790686,0,0,43.51754385964912,152.23174641469322,ZNF469
GO_Biological_Process_2023,Positive Regulation Of Hydrolase Activity (GO:0051345),1/176,0.0347404520666623,0.0539075980344759,0,0,37.754285714285714,126.84875593802872,EZH2
GO_Biological_Process_2023,Regulation Of GTPase Activity (GO:0043087),1/214,0.0421208378090414,0.0631812567135622,0,0,30.95931142410016,98.05472435387836,EZH2
GO_Biological_Process_2023,Positive Regulation Of GTPase Activity (GO:0043547),1/234,0.0459882098807563,0.0667570788591625,0,0,28.273247496423465,87.06379642779046,EZH2
GO_Biological_Process_2023,Negative Regulation Of Signal Transduction (GO:0009968),1/267,0.0523437577600881,0.0710084409306929,0,0,24.72431077694236,72.93480286504084,EZH2
GO_Biological_Process_2023,Chromatin Organization (GO:0006325),1/268,0.0525358530582794,0.0710084409306929,0,0,24.630461922596755,72.5677306325238,EZH2
GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),2/2028,0.0536508220365235,0.0710084409306929,0,0,8.86969397828233,25.94614759427968,ZNF469;EZH2
GO_Biological_Process_2023,Positive Regulation Of Cell Differentiation (GO:0045597),1/283,0.0554137796166174,0.0712462880785081,0,0,23.30260047281324,67.41272176611194,EZH2
GO_Biological_Process_2023,Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.060577520270055,0.0757219003375687,0,0,21.23732470334412,59.54587801166977,EZH2
GO_Biological_Process_2023,Negative Regulation Of Gene Expression (GO:0010629),1/336,0.0655299740425344,0.079698617078758,0,0,19.56318407960199,53.31452089259459,EZH2
GO_Biological_Process_2023,Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.0751875015499583,0.0890378307828453,0,0,16.934369602763386,43.82225810833037,EZH2
GO_Biological_Process_2023,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),1/452,0.0873873875851138,0.0991509593378949,0,0,14.445676274944567,35.20995366455744,EZH2
GO_Biological_Process_2023,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),1/456,0.0881341860781288,0.0991509593378949,0,0,14.315750915750916,34.77145272971057,EZH2
GO_Biological_Process_2023,Positive Regulation Of Cell Population Proliferation (GO:0008284),1/483,0.0931630946831565,0.1022521770912694,0,0,13.495159059474412,32.029459303581746,EZH2
GO_Biological_Process_2023,Positive Regulation Of Cellular Process (GO:0048522),1/594,0.1136192884864765,0.1217349519497962,0,0,10.906689151208544,23.720979983921744,EZH2
GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),1/766,0.1446311012447771,0.1513581292096505,0,0,8.379520697167756,16.202380681510128,EZH2
GO_Biological_Process_2023,Regulation Of Gene Expression (GO:0010468),1/1127,0.2070675046327445,0.2117735842834887,0,0,5.586145648312611,8.796561813338137,EZH2
GO_Biological_Process_2023,Regulation Of DNA-templated Transcription (GO:0006355),1/1922,0.332474284051567,0.332474284051567,0,0,3.136387298282145,3.453766995070241,EZH2
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0095661100512231,0.0357744566849063,0,0,141.4822695035461,657.8258626058753,GNPNAT1
KEGG_2021_Human,Lysine degradation,1/63,0.0125414091070478,0.0357744566849063,0,0,107.17204301075267,469.2763018440373,EZH2
KEGG_2021_Human,Morphine addiction,1/91,0.0180773648602116,0.0357744566849063,0,0,73.72592592592592,295.8691213711147,PDE4C
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0210334647272819,0.0357744566849063,0,0,63.14603174603175,243.8472768368076,PDE4C
KEGG_2021_Human,Purine metabolism,1/129,0.0255531833463616,0.0357744566849063,0,0,51.739583333333336,189.7287094266052,PDE4C
KEGG_2021_Human,cAMP signaling pathway,1/216,0.0425081031791539,0.0495927870423462,0,0,30.668217054263565,96.8520866689796,PDE4C
KEGG_2021_Human,MicroRNAs in cancer,1/310,0.060577520270055,0.060577520270055,0,0,21.23732470334412,59.54587801166977,EZH2
